FROM AMAZING ISRAEL: NEW VACCINE TRIGGERS RESPONSE IN 90% OF CANCER TYPES…JONATHAN NEFF SEE NOTE PLEASE

Posted By on January 10th, 2015 


http://nocamels.com/2015/01/new-vaccine-for-cancer/

MUST BE DENIED TO THE BDS (BASTARDS TO DIVEST AND SANCTION)….RSK

New Israeli Cancer Vaccine Triggers Response In 90% Of Cancer Types

There’s no doubt that cancer is one of the world’s most vicious
diseases. For decades, scientists have been trying to find a cure for
cancer, a terminal illness that kills 8 million people worldwide every
year. With 14 million new cancer cases diagnosed around the globe
every year, according to the World Health Organization, the need for
prevention is vital. Now, an Israeli biotechnology company is
developing a vaccine for cancer, which is not designed to treat the
disease – but to prevent it from returning.

Vaxil BioTherapeutics, based in Nes Ziona, Israel, has spent over half
a decade developing ImMucin, a prophylactic cancer vaccine, which can
trigger a response in about 90 percent of all types of cancer,
according to the company.

Immunotherapy: A hybrid cross between a vaccine and a drug

“Vaxil is developing a drug to keep the cancer from coming back,”
Julian Levy, Vaxil’s CFO, tells NoCamels.com. “We are trying to
harness the natural power of the immune system to fight against cancer
by seeking out cancer cells and destroying them.”

Levy explains that ImMucin is not a replacement for traditional cancer
treatments such as chemotherapy or radiation. Rather, the company is
targeting a different stage in the patient’s battle against cancer,
specifically the early stages of the detection, as well as during
remission. That’s why, unfortunately, the drug won’t be helpful to
many cancer patients – specifically those who are in advanced stages
of the disease – because it requires a relatively healthy body to be
fully effective.

Even though ImMucin is a vaccine, it is given to people who are
already sick, unlike traditional vaccines. So, while ImMucin’s
scientific mechanism is one of a vaccine, from the point of view of
the patient, it acts exactly like a drug that has physiological
effects when introduced to the body.

“Many preventative cancer vaccines today are not actual vaccines
against cancer,” Levy says. “Young women can take a vaccine for the
HPV virus, which doesn’t combat cancer; it’s a vaccine against a virus
that has been proven to lead to a more serious cervical cancer.”

Training the immune system to attack cancerous cells

ImMucin works by stimulating a part of the immune system and teaching
it to attack certain cells with certain markers that indicate the
presence of cancer. When the drug is introduced during an early stage
of cancer, the hope is that as a patient’s cancer begins to creep
back, the immune system is trained appropriately to know which cells
to destroy and which to leave be.

This immune response has been consistent throughout Vaxil’s clinical
trials on the vaccine over the past few years. The company ran trials
exclusively on Multiple Myeloma patients until January 2014, when it
began trials on breast cancer patients.

Vaxil’s current switch from successful myeloma trials to breast cancer
trials would certainly turn some heads in the biotech community.
That’s because typically, when a drug has this much success on a
certain type of cancer, a company would provide more resources to
finish the trials (through Phase III) and get it to market – it
wouldn’t delve into new projects.

Vaxil’s most recent valuation is just under $3 million. In the US,
clinical trials and ongoing research and development can cost hundreds
of millions of dollars per drug, and it’s very possible that Vaxil
doesn’t have the cash to push ImMucin to the market at this point.
However, Levy is confident that ImMucin will be on the market by the
end of this decade.

Vaxil BioTheraputics has promising technology and initial clinical
success, especially since ImMucin has the potential to treat 90
percent of cancers found in patients. Certainly, this kind of
immunotherapy for an illness previously thought of as incurable, gives
hope to millions of patients and their families.

[Video]

http://nocamels.com/2015/01/new-vaccine-for-cancer/
Categorized under: ANTI-SEMITISM.
Tagged with: no tags.

Comments are closed.